JFU - LYFT CPE and VSTO among premarket gainers

Five Prime Therapeutics (FPRX +303% on positive topline results from the global Phase 2 FIGHT trial, enrolling 155 patients.Immuron (IMRN +27% on positive vaccine responses in gut mediated pathogens.fuboTV (FUBO +28% on Q3 results.Genfit SA (GNFT) +26%.Surface Oncology (SURF +10% on Fast Track tag for SRF388.Myomo (MYO +15% on Q3 results.Eastside Distilling (EAST) +11%.Asia Pacific Wire & Cable (APWC) +9%.Clearside Biomedical (CLSD +8% on Q3 results.Abeona Therapeutics (ABEO) +8%.Vista Outdoor (VSTO) +9%.Co-Diagnostics (CODX +7% after its CoPrimers effective in COVID-19 saliva PCR tests.Callon Petroleum (CPE) +6%.9F (JFU) +6%.Lyft (LYFT +6% on Q3 results.Ruhnn Holding (RUHN) +5%.Evogene (EVGN +6% on receiving an IMC-GAP approval from the Israel Medical Cannabis Agency for the commercial operation of its propagation farm.

For further details see:

LYFT, CPE and VSTO among premarket gainers